secwatch.observer — SEC 8-K summary
======================================

Issuer:     BeOne Medicines Ltd. (ONC)
CIK:        0001651308
Form:       8-K
Filed at:   2026-06-11T20:13:24+00:00
Accession:  0001651308-26-000017
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BeOne Medicines shareholders approve 75.4M share increase in 2016 incentive plan
--------------------------------------------------------------------------------

- Shareholders approved Fifth Amended 2016 Plan, adding 75,400,000 ordinary shares; and Sixth Amended 2018 ESPP, adding 3,250,000 ordinary shares.
- Four directors (Goller, Krishana, Sanders, Yi) did not stand for re-election; no disagreement with the company.
- Directors re-elected included Brandicourt, Dugan, Hooper, Oyler, Riva, Sharp, Wang; new directors Baker, Mooney, Sawyers elected.
- Connected Person Placing Authorization for Amgen up to 5-year rolling term passed with 458M for, 331M against, 271M abstentions.
- General Mandate to Issue Shares (up to 20% of issued shares) and to Repurchase Shares (up to 10%) both approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1651308/000165130826000017/0001651308-26-000017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1651308/000165130826000017/bgne-20260611.htm
  HTML page:      https://secwatch.observer/filing/0001651308-26-000017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer